Global Small Molecular API Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1045

A small molecule is a low molecular weight (< 900 daltons) organic compound that may regulate a biological process, with a size on the order of 1 nm. Most drugs are small molecules. Larger structures such as nucleic acids and proteins, and many polysaccharides are not small molecules, although their constituent monomers (ribo- or deoxyribonucleotides, amino acids, and monosaccharides, respectively) are often considered small molecules. Small molecules may be used as research tools to probe biological function as well as leads in the development of new therapeutic agents. Some can inhibit a specific function of a protein or disrupt protein–protein interactions.
Globally North America is the largest market for small molecule API. Europe is the second-largest market for small molecule API. Furthermore Asia pacific market is expected to be the fastest growing market for small molecule API.
In 2018, the global Small Molecular API market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Small Molecular API status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Small Molecular API development in United States, Europe and China.

The key players covered in this study
Albemarle Corporation
Allergan Plc.
Aurobindo Pharma
Cambrex Corporation
Dr. Reddy’s Laboratories Ltd.
Glaxosmithkline Plc.
Lonza
Merck Sharp & Dohme Corp.
Mylan N.V.
Novartis AG
Pfizer Inc.
Siegfried AG
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Market segment by Type, the product can be split into
Synthetic/Chemical API
Biological API

Market segment by Application, split into
Cardiovascular
Oncology
Diabetes
Immunological Disorders
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Small Molecular API status, future forecast, growth opportunity, key market and key players.
To present the Small Molecular API development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Small Molecular API are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Small Molecular API Market Size Growth Rate by Type (2014-2025)
1.4.2 Synthetic/Chemical API
1.4.3 Biological API
1.5 Market by Application
1.5.1 Global Small Molecular API Market Share by Application (2014-2025)
1.5.2 Cardiovascular
1.5.3 Oncology
1.5.4 Diabetes
1.5.5 Immunological Disorders
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Small Molecular API Market Size
2.2 Small Molecular API Growth Trends by Regions
2.2.1 Small Molecular API Market Size by Regions (2014-2025)
2.2.2 Small Molecular API Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Small Molecular API Market Size by Manufacturers
3.1.1 Global Small Molecular API Revenue by Manufacturers (2014-2019)
3.1.2 Global Small Molecular API Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Small Molecular API Market Concentration Ratio (CR5 and HHI)
3.2 Small Molecular API Key Players Head office and Area Served
3.3 Key Players Small Molecular API Product/Solution/Service
3.4 Date of Enter into Small Molecular API Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Small Molecular API Market Size by Type (2014-2019)
4.2 Global Small Molecular API Market Size by Application (2014-2019)

5 United States
5.1 United States Small Molecular API Market Size (2014-2019)
5.2 Small Molecular API Key Players in United States
5.3 United States Small Molecular API Market Size by Type
5.4 United States Small Molecular API Market Size by Application

6 Europe
6.1 Europe Small Molecular API Market Size (2014-2019)
6.2 Small Molecular API Key Players in Europe
6.3 Europe Small Molecular API Market Size by Type
6.4 Europe Small Molecular API Market Size by Application

7 China
7.1 China Small Molecular API Market Size (2014-2019)
7.2 Small Molecular API Key Players in China
7.3 China Small Molecular API Market Size by Type
7.4 China Small Molecular API Market Size by Application

8 Japan
8.1 Japan Small Molecular API Market Size (2014-2019)
8.2 Small Molecular API Key Players in Japan
8.3 Japan Small Molecular API Market Size by Type
8.4 Japan Small Molecular API Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Small Molecular API Market Size (2014-2019)
9.2 Small Molecular API Key Players in Southeast Asia
9.3 Southeast Asia Small Molecular API Market Size by Type
9.4 Southeast Asia Small Molecular API Market Size by Application

10 India
10.1 India Small Molecular API Market Size (2014-2019)
10.2 Small Molecular API Key Players in India
10.3 India Small Molecular API Market Size by Type
10.4 India Small Molecular API Market Size by Application

11 Central & South America
11.1 Central & South America Small Molecular API Market Size (2014-2019)
11.2 Small Molecular API Key Players in Central & South America
11.3 Central & South America Small Molecular API Market Size by Type
11.4 Central & South America Small Molecular API Market Size by Application

12 International Players Profiles
12.1 Albemarle Corporation
12.1.1 Albemarle Corporation Company Details
12.1.2 Company Description and Business Overview
12.1.3 Small Molecular API Introduction
12.1.4 Albemarle Corporation Revenue in Small Molecular API Business (2014-2019)
12.1.5 Albemarle Corporation Recent Development
12.2 Allergan Plc.
12.2.1 Allergan Plc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Small Molecular API Introduction
12.2.4 Allergan Plc. Revenue in Small Molecular API Business (2014-2019)
12.2.5 Allergan Plc. Recent Development
12.3 Aurobindo Pharma
12.3.1 Aurobindo Pharma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Small Molecular API Introduction
12.3.4 Aurobindo Pharma Revenue in Small Molecular API Business (2014-2019)
12.3.5 Aurobindo Pharma Recent Development
12.4 Cambrex Corporation
12.4.1 Cambrex Corporation Company Details
12.4.2 Company Description and Business Overview
12.4.3 Small Molecular API Introduction
12.4.4 Cambrex Corporation Revenue in Small Molecular API Business (2014-2019)
12.4.5 Cambrex Corporation Recent Development
12.5 Dr. Reddy’s Laboratories Ltd.
12.5.1 Dr. Reddy’s Laboratories Ltd. Company Details
12.5.2 Company Description and Business Overview
12.5.3 Small Molecular API Introduction
12.5.4 Dr. Reddy’s Laboratories Ltd. Revenue in Small Molecular API Business (2014-2019)
12.5.5 Dr. Reddy’s Laboratories Ltd. Recent Development
12.6 Glaxosmithkline Plc.
12.6.1 Glaxosmithkline Plc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Small Molecular API Introduction
12.6.4 Glaxosmithkline Plc. Revenue in Small Molecular API Business (2014-2019)
12.6.5 Glaxosmithkline Plc. Recent Development
12.7 Lonza
12.7.1 Lonza Company Details
12.7.2 Company Description and Business Overview
12.7.3 Small Molecular API Introduction
12.7.4 Lonza Revenue in Small Molecular API Business (2014-2019)
12.7.5 Lonza Recent Development
12.8 Merck Sharp & Dohme Corp.
12.8.1 Merck Sharp & Dohme Corp. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Small Molecular API Introduction
12.8.4 Merck Sharp & Dohme Corp. Revenue in Small Molecular API Business (2014-2019)
12.8.5 Merck Sharp & Dohme Corp. Recent Development
12.9 Mylan N.V.
12.9.1 Mylan N.V. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Small Molecular API Introduction
12.9.4 Mylan N.V. Revenue in Small Molecular API Business (2014-2019)
12.9.5 Mylan N.V. Recent Development
12.10 Novartis AG
12.10.1 Novartis AG Company Details
12.10.2 Company Description and Business Overview
12.10.3 Small Molecular API Introduction
12.10.4 Novartis AG Revenue in Small Molecular API Business (2014-2019)
12.10.5 Novartis AG Recent Development
12.11 Pfizer Inc.
12.12 Siegfried AG
12.13 Sun Pharmaceutical Industries Ltd.
12.14 Teva Pharmaceutical Industries Ltd.

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details